AC-262,356
Identifiers | |
---|---|
| |
CAS Number |
870888-46-3 871032-12-1 (exo form) |
ChemSpider | 31129035 |
UNII | U8VS41J5O6 |
ChEMBL | CHEMBL3084525 |
Chemical and physical data | |
Formula | C18H18N2O |
Molar mass | 278.348 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
AC-262536 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator. Chemically it possesses endo-exo isomerism, with the endo form being the active form. It acts as a partial agonist for the androgen receptor with a Ki of 5nM, and no significant affinity for any other receptors tested. In animal studies it produced a maximal effect of around 66% of the anabolic action of testosterone, but only around 27% of its potency as an androgen.[1]
References
- ↑ Piu, F; Gardell, LR; Son, T; Schlienger, N; Lund, BW; Schiffer, HH; Vanover, KE; Davis, RE; Olsson, R; Bradley, SR (2008). "Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator". The Journal of Steroid Biochemistry and Molecular Biology. 109 (1–2): 129–37. doi:10.1016/j.jsbmb.2007.11.001. PMID 18164613.
This article is issued from Wikipedia - version of the 11/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.